Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Clinical Genomic Profiling of a Diverse Array of Oncology Specimens at a Large Academic Cancer Center: Identification of Targetable Variants and Experience with Reimbursement.

Sireci AN, Aggarwal VS, Turk AT, Gindin T, Mansukhani MM, Hsiao SJ.

J Mol Diagn. 2017 Mar;19(2):277-287. doi: 10.1016/j.jmoldx.2016.10.008. Epub 2016 Dec 23.

PMID:
28024947
2.

Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.

Oberg JA, Glade Bender JL, Sulis ML, Pendrick D, Sireci AN, Hsiao SJ, Turk AT, Dela Cruz FS, Hibshoosh H, Remotti H, Zylber RJ, Pang J, Diolaiti D, Koval C, Andrews SJ, Garvin JH, Yamashiro DJ, Chung WK, Emerson SG, Nagy PL, Mansukhani MM, Kung AL.

Genome Med. 2016 Dec 23;8(1):133. doi: 10.1186/s13073-016-0389-6.

3.

A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma.

Dela Cruz FS, Diolaiti D, Turk AT, Rainey AR, Ambesi-Impiombato A, Andrews SJ, Mansukhani MM, Nagy PL, Alvarez MJ, Califano A, Forouhar F, Modzelewski B, Mitchell CM, Yamashiro DJ, Marks LJ, Glade Bender JL, Kung AL.

Genome Med. 2016 Oct 31;8(1):116. doi: 10.1186/s13073-016-0366-0.

4.

Inter-Observer Variation in the Pathologic Identification of Extranodal Extension in Nodal Metastasis from Papillary Thyroid Carcinoma.

Du E, Wenig BM, Su HK, Rowe ME, Haser GC, Asa SL, Baloch Z, Faquin WC, Fellegara G, Giordano T, Ghossein R, LiVolsi VA, Lloyd R, Mete O, Ozbek U, Rosai J, Suster S, Thompson LD, Turk AT, Urken ML.

Thyroid. 2016 Jun;26(6):816-9. doi: 10.1089/thy.2015.0551.

PMID:
27089928
5.

Inter-Observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma.

Su HK, Wenig BM, Haser GC, Rowe ME, Asa SL, Baloch Z, Du E, Faquin WC, Fellegara G, Giordano T, Ghossein R, LiVolsi VA, Lloyd R, Mete O, Ozbek U, Rosai J, Suster S, Thompson LD, Turk AT, Urken ML.

Thyroid. 2016 Apr;26(4):512-7. doi: 10.1089/thy.2015.0508.

PMID:
26953223
6.

Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.

Qiu W, Tang SM, Lee S, Turk AT, Sireci AN, Qiu A, Rose C, Xie C, Kitajewski J, Wen HJ, Crawford HC, Sims PA, Hruban RH, Remotti HE, Su GH.

Gastroenterology. 2016 Jan;150(1):218-228.e12. doi: 10.1053/j.gastro.2015.09.013. Epub 2015 Sep 25.

7.

Close surgical margins after radical prostatectomy mimic biochemical recurrence rates of positive margins.

Whalen MJ, Shapiro EY, Rothberg MB, Turk AT, Woldu SL, Roy Choudhury A, Patel T, Badani KK.

Urol Oncol. 2015 Nov;33(11):494.e9-494.e14. doi: 10.1016/j.urolonc.2015.07.005. Epub 2015 Aug 8.

PMID:
26259665
9.

Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma.

Qiu W, Tong GX, Turk AT, Close LG, Caruana SM, Su GH.

Biomed Res Int. 2014;2014:810487. doi: 10.1155/2014/810487. Epub 2014 Jan 8.

10.

Extrathyroidal extension predicts extranodal extension in patients with positive lymph nodes: an important association that may affect clinical management.

Clain JB, Scherl S, Dos Reis L, Turk A, Wenig BM, Mehra S, Karle WE, Urken ML.

Thyroid. 2014 Jun;24(6):951-7. doi: 10.1089/thy.2013.0557. Epub 2014 May 5.

PMID:
24443878
11.

Pitfalls in the biopsy diagnosis of intraoral minor salivary gland neoplasms: diagnostic considerations and recommended approach.

Turk AT, Wenig BM.

Adv Anat Pathol. 2014 Jan;21(1):1-11. doi: 10.1097/PAP.0000000000000000. Review.

PMID:
24316905
12.

Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.

Garcia-Carracedo D, Turk AT, Fine SA, Akhavan N, Tweel BC, Parsons R, Chabot JA, Allendorf JD, Genkinger JM, Remotti HE, Su GH.

Clin Cancer Res. 2013 Dec 15;19(24):6830-41. doi: 10.1158/1078-0432.CCR-13-0624. Epub 2013 Oct 16.

13.

Portal Hypertension, Nodular Regenerative Hyperplasia of the Liver, and Obstructive Portal Venopathy due to Metastatic Breast Cancer.

Turk AT, Szabolcs MJ, Lefkowitch JH.

Case Rep Pathol. 2013;2013:826284. doi: 10.1155/2013/826284. Epub 2013 Jul 31.

14.

Micropapillary urothelial carcinoma: Cytologic features in a retrospective series of urine specimens.

Heymann JJ, Saqi A, Turk AT, Crapanzano J.

Cytojournal. 2013 Feb 28;10:4. doi: 10.4103/1742-6413.107986. Print 2013.

15.

Pathological confirmation of nerve-sparing types performed during robot-assisted radical prostatectomy (RARP).

Ko WJ, Hruby GW, Turk AT, Landman J, Badani KK.

BJU Int. 2013 Mar;111(3):451-8. doi: 10.1111/j.1464-410X.2012.11393.x. Epub 2012 Aug 20.

16.

Mixed corticomedullary carcinoma of the adrenal gland: a case report.

Turk AT, Asad H, Trapasso J, Perilli G, LiVolsi VA.

Endocr Pract. 2012 May-Jun;18(3):e37-42. doi: 10.4158/EP11222.CR. Review.

PMID:
22548942
17.

Gleason score concordance on biopsy-confirmed prostate cancer: is pathological re-evaluation necessary prior to radical prostatectomy?

Truesdale MD, Cheetham PJ, Turk AT, Sartori S, Hruby GW, Dinneen EP, Benson MC, Badani KK.

BJU Int. 2011 Mar;107(5):749-54. doi: 10.1111/j.1464-410X.2010.09570.x. Epub 2010 Sep 14.

18.

Pax8: a marker for carcinoma of Müllerian origin in serous effusions.

Tong GX, Devaraj K, Hamele-Bena D, Yu WM, Turk A, Chen X, Wright JD, Greenebaum E.

Diagn Cytopathol. 2011 Aug;39(8):567-74. doi: 10.1002/dc.21426. Epub 2010 Jul 6.

PMID:
20607683
19.
20.

Associations of serum sex hormone binding globulin (SHBG) levels with SHBG gene polymorphisms in the CARDIA Male Hormone Study.

Turk A, Kopp P, Colangelo LA, Urbanek M, Wood K, Liu K, Skinner HG, Gapstur SM.

Am J Epidemiol. 2008 Feb 15;167(4):412-8. Epub 2007 Dec 4.

PMID:
18056923

Supplemental Content

Loading ...
Support Center